1. Home
  2. AZTR vs NVVE Comparison

AZTR vs NVVE Comparison

Compare AZTR & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • NVVE
  • Stock Information
  • Founded
  • AZTR 2014
  • NVVE 1996
  • Country
  • AZTR United States
  • NVVE United States
  • Employees
  • AZTR N/A
  • NVVE N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • AZTR Health Care
  • NVVE Energy
  • Exchange
  • AZTR Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • AZTR 3.2M
  • NVVE 2.2M
  • IPO Year
  • AZTR 2023
  • NVVE N/A
  • Fundamental
  • Price
  • AZTR $0.29
  • NVVE $2.74
  • Analyst Decision
  • AZTR
  • NVVE
  • Analyst Count
  • AZTR 0
  • NVVE 0
  • Target Price
  • AZTR N/A
  • NVVE N/A
  • AVG Volume (30 Days)
  • AZTR 4.7M
  • NVVE 115.9K
  • Earning Date
  • AZTR 03-14-2025
  • NVVE 03-27-2025
  • Dividend Yield
  • AZTR N/A
  • NVVE N/A
  • EPS Growth
  • AZTR N/A
  • NVVE N/A
  • EPS
  • AZTR N/A
  • NVVE N/A
  • Revenue
  • AZTR $97,500.00
  • NVVE $5,144,831.00
  • Revenue This Year
  • AZTR N/A
  • NVVE $200.61
  • Revenue Next Year
  • AZTR N/A
  • NVVE $109.43
  • P/E Ratio
  • AZTR N/A
  • NVVE N/A
  • Revenue Growth
  • AZTR N/A
  • NVVE N/A
  • 52 Week Low
  • AZTR $0.23
  • NVVE $2.23
  • 52 Week High
  • AZTR $38.10
  • NVVE $17.30
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 44.02
  • NVVE 42.47
  • Support Level
  • AZTR $0.24
  • NVVE $2.30
  • Resistance Level
  • AZTR $0.59
  • NVVE $2.94
  • Average True Range (ATR)
  • AZTR 0.05
  • NVVE 0.43
  • MACD
  • AZTR 0.01
  • NVVE -0.02
  • Stochastic Oscillator
  • AZTR 10.56
  • NVVE 19.07

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: